Cargando…

Cancer Predisposition Syndromes and Medulloblastoma in the Molecular Era

Medulloblastoma is the most common malignant brain tumor in children. In addition to sporadic cases, medulloblastoma may occur in association with cancer predisposition syndromes. This review aims to provide a complete description of inherited cancer syndromes associated with medulloblastoma. We exa...

Descripción completa

Detalles Bibliográficos
Autores principales: Carta, Roberto, Del Baldo, Giada, Miele, Evelina, Po, Agnese, Besharat, Zein Mersini, Nazio, Francesca, Colafati, Giovanna Stefania, Piccirilli, Eleonora, Agolini, Emanuele, Rinelli, Martina, Lodi, Mariachiara, Cacchione, Antonella, Carai, Andrea, Boccuto, Luigi, Ferretti, Elisabetta, Locatelli, Franco, Mastronuzzi, Angela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7658916/
https://www.ncbi.nlm.nih.gov/pubmed/33194646
http://dx.doi.org/10.3389/fonc.2020.566822
_version_ 1783608748730744832
author Carta, Roberto
Del Baldo, Giada
Miele, Evelina
Po, Agnese
Besharat, Zein Mersini
Nazio, Francesca
Colafati, Giovanna Stefania
Piccirilli, Eleonora
Agolini, Emanuele
Rinelli, Martina
Lodi, Mariachiara
Cacchione, Antonella
Carai, Andrea
Boccuto, Luigi
Ferretti, Elisabetta
Locatelli, Franco
Mastronuzzi, Angela
author_facet Carta, Roberto
Del Baldo, Giada
Miele, Evelina
Po, Agnese
Besharat, Zein Mersini
Nazio, Francesca
Colafati, Giovanna Stefania
Piccirilli, Eleonora
Agolini, Emanuele
Rinelli, Martina
Lodi, Mariachiara
Cacchione, Antonella
Carai, Andrea
Boccuto, Luigi
Ferretti, Elisabetta
Locatelli, Franco
Mastronuzzi, Angela
author_sort Carta, Roberto
collection PubMed
description Medulloblastoma is the most common malignant brain tumor in children. In addition to sporadic cases, medulloblastoma may occur in association with cancer predisposition syndromes. This review aims to provide a complete description of inherited cancer syndromes associated with medulloblastoma. We examine their epidemiological, clinical, genetic, and diagnostic features and therapeutic approaches, including their correlation with medulloblastoma. Furthermore, according to the most recent molecular advances, we describe the association between the various molecular subgroups of medulloblastoma and each cancer predisposition syndrome. Knowledge of the aforementioned conditions can guide pediatric oncologists in performing adequate cancer surveillance. This will allow clinicians to promptly diagnose and treat medulloblastoma in syndromic children, forming a team with all specialists necessary for the correct management of the other various manifestations/symptoms related to the inherited cancer syndromes.
format Online
Article
Text
id pubmed-7658916
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-76589162020-11-13 Cancer Predisposition Syndromes and Medulloblastoma in the Molecular Era Carta, Roberto Del Baldo, Giada Miele, Evelina Po, Agnese Besharat, Zein Mersini Nazio, Francesca Colafati, Giovanna Stefania Piccirilli, Eleonora Agolini, Emanuele Rinelli, Martina Lodi, Mariachiara Cacchione, Antonella Carai, Andrea Boccuto, Luigi Ferretti, Elisabetta Locatelli, Franco Mastronuzzi, Angela Front Oncol Oncology Medulloblastoma is the most common malignant brain tumor in children. In addition to sporadic cases, medulloblastoma may occur in association with cancer predisposition syndromes. This review aims to provide a complete description of inherited cancer syndromes associated with medulloblastoma. We examine their epidemiological, clinical, genetic, and diagnostic features and therapeutic approaches, including their correlation with medulloblastoma. Furthermore, according to the most recent molecular advances, we describe the association between the various molecular subgroups of medulloblastoma and each cancer predisposition syndrome. Knowledge of the aforementioned conditions can guide pediatric oncologists in performing adequate cancer surveillance. This will allow clinicians to promptly diagnose and treat medulloblastoma in syndromic children, forming a team with all specialists necessary for the correct management of the other various manifestations/symptoms related to the inherited cancer syndromes. Frontiers Media S.A. 2020-10-29 /pmc/articles/PMC7658916/ /pubmed/33194646 http://dx.doi.org/10.3389/fonc.2020.566822 Text en Copyright © 2020 Carta, Del Baldo, Miele, Po, Besharat, Nazio, Colafati, Piccirilli, Agolini, Rinelli, Lodi, Cacchione, Carai, Boccuto, Ferretti, Locatelli and Mastronuzzi http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Carta, Roberto
Del Baldo, Giada
Miele, Evelina
Po, Agnese
Besharat, Zein Mersini
Nazio, Francesca
Colafati, Giovanna Stefania
Piccirilli, Eleonora
Agolini, Emanuele
Rinelli, Martina
Lodi, Mariachiara
Cacchione, Antonella
Carai, Andrea
Boccuto, Luigi
Ferretti, Elisabetta
Locatelli, Franco
Mastronuzzi, Angela
Cancer Predisposition Syndromes and Medulloblastoma in the Molecular Era
title Cancer Predisposition Syndromes and Medulloblastoma in the Molecular Era
title_full Cancer Predisposition Syndromes and Medulloblastoma in the Molecular Era
title_fullStr Cancer Predisposition Syndromes and Medulloblastoma in the Molecular Era
title_full_unstemmed Cancer Predisposition Syndromes and Medulloblastoma in the Molecular Era
title_short Cancer Predisposition Syndromes and Medulloblastoma in the Molecular Era
title_sort cancer predisposition syndromes and medulloblastoma in the molecular era
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7658916/
https://www.ncbi.nlm.nih.gov/pubmed/33194646
http://dx.doi.org/10.3389/fonc.2020.566822
work_keys_str_mv AT cartaroberto cancerpredispositionsyndromesandmedulloblastomainthemolecularera
AT delbaldogiada cancerpredispositionsyndromesandmedulloblastomainthemolecularera
AT mieleevelina cancerpredispositionsyndromesandmedulloblastomainthemolecularera
AT poagnese cancerpredispositionsyndromesandmedulloblastomainthemolecularera
AT besharatzeinmersini cancerpredispositionsyndromesandmedulloblastomainthemolecularera
AT naziofrancesca cancerpredispositionsyndromesandmedulloblastomainthemolecularera
AT colafatigiovannastefania cancerpredispositionsyndromesandmedulloblastomainthemolecularera
AT piccirillieleonora cancerpredispositionsyndromesandmedulloblastomainthemolecularera
AT agoliniemanuele cancerpredispositionsyndromesandmedulloblastomainthemolecularera
AT rinellimartina cancerpredispositionsyndromesandmedulloblastomainthemolecularera
AT lodimariachiara cancerpredispositionsyndromesandmedulloblastomainthemolecularera
AT cacchioneantonella cancerpredispositionsyndromesandmedulloblastomainthemolecularera
AT caraiandrea cancerpredispositionsyndromesandmedulloblastomainthemolecularera
AT boccutoluigi cancerpredispositionsyndromesandmedulloblastomainthemolecularera
AT ferrettielisabetta cancerpredispositionsyndromesandmedulloblastomainthemolecularera
AT locatellifranco cancerpredispositionsyndromesandmedulloblastomainthemolecularera
AT mastronuzziangela cancerpredispositionsyndromesandmedulloblastomainthemolecularera